• Software
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Regulatory Strategies
      • Pro-ficiency | Clinical Simulations & Medical Communications (CSMC)
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • Pulmonary Package
    • Concierge
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
  • Search
Simulations Plus logo
Simulations Plus logo

Simulations Plus

We Improve Health Through Innovative Solutions

  • Software
      • GastroPlus®
      • MonolixSuite™
      • ADMET Predictor®
      • DILIsym®
      • DDDPlus™
      • NAFLDsym®
      • MembranePlus™
      • Monolix®
      • OBESITYsym™
      • PKanalix®
      • Simulx®
      • IPFsym®
      • ILDsym®
      • RENAsym®
      • MedChem Designer™
      • Pro-ficiency Performance Management
      • Panorama KOL Insights Engine
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Quantitative Systems Pharmacology (QSP)
      • Physiologically Based Pharmacokinetic (PBPK) Software
      • Cheminformatics
      • Pro-ficiency | Clinical Simulations & Medical Communications (CSMC)
      • Software Packages
        • Consult + Coach
        • Plug ‘n’ Play
        • Pulmonary Package
        • First-in-Human Simulator
        • EvolvePK+
      • University+
  • Services
    • Consulting Services
      • Early Drug Discovery
      • Physiologically Based Pharmacokinetics (PBPK)
      • Quantitative Systems Pharmacology (QSP)
      • Clinical Pharmacology & Pharmacometrics (CPP)
      • Regulatory Strategies
      • Pro-ficiency | Clinical Simulations & Medical Communications (CSMC)
    • Consulting Packages
      • Consult + Coach
      • First-in-Human Simulator
      • Pulmonary Package
    • Concierge
    • Learning Services
  • Events
    • Upcoming Events
    • Webinars
    • Live Workshops
    • On Demand Workshops
    • Scientific Meetings
    • Past Events
  • Resource Center
    • Blog
    • Journal Articles
    • Flyers
    • Posters
    • Presentations
    • Press Releases
    • Videos
    • White Papers
    • Webinars
  • Careers
  • Investors
    • Conference Calls & Presentations
    • Environmental, Social and Governance (ESG)
    • Corporate Profile
    • Board of Directors
    • SEC Filings
    • Press Releases
    • Shareholder Information
    • Corporate Development Initiative
  • About
    • Our Team
    • Leadership
    • Partners and Collaborators
    • Privacy Notice
    • Contact Us
  • Support
    • Customer Portal
    • Datasheets
    • Software Installation
    • Contact Support
U.S. FDA Renews and Expands GastroPlus(TM) Software License
View More
U.S. FDA Renews and Expands GastroPlus(TM) Software License
  • April 9, 2008
  • Press Release

U.S. FDA Renews and Expands GastroPlus(TM) Software License

Keywords: absorption, biopharmaceutical, PBPK modeling, physicochemical properties, The U.S. Food and Drug Administration
Software: GastroPlus®
Division: PBPK

Adds New ADMET Predictor(TM) Module

  • Read More
Simulations Plus’ Software Selected Application of Choice by Premier Pharmaceutical Company
  • April 3, 2008
  • Press Release

Simulations Plus’ Software Selected Application of Choice by Premier Pharmaceutical Company

Keywords: biopharmaceutical, in vitro dissolution experiment simulation software, Multi-year Agreement, PBPK modeling, pharmaceutical
Division: PBPK

Top 3 Company Adds Software Licenses to Multi-year Agreement

  • Read More
Simulations Plus Releases Major Upgrade to ADMET Predictor™ Software
  • March 18, 2008
  • Press Release

Simulations Plus Releases Major Upgrade to ADMET Predictor™ Software

Keywords: absorption distribution metabolism and excretion (ADME), ADMET cheminformatics, cytochrome P450 (CYP), human, hydroxylation, metabolism, molecular property prediction software, Toxicity
Software: ADMET Predictor®
Division: PBPK

Version 2.4 Adds Industry’s First Metabolism Kinetics Module for Key Enzymes

  • Read More
Simulations Plus’ CEO Addresses Investor Inquiries
  • March 7, 2008
  • Press Release

Simulations Plus’ CEO Addresses Investor Inquiries

Keywords: investor relations
Division: PBPK
  • Read More
Simulations Plus Reports First Quarter FY2008 Financial Results
  • January 14, 2008
  • Press Release

Simulations Plus Reports First Quarter FY2008 Financial Results

Keywords: financial results, gross profit, investor relations, net revenues
Division: PBPK

Revenues Increase 36%, Earnings Increase 232%

  • Read More
Simulations Plus Releases Major Upgrade To ClassPharmer™ Software
  • October 17, 2007
  • Press Release

Simulations Plus Releases Major Upgrade To ClassPharmer™ Software

Keywords: cheminformatics, ClassPharmer, International Society for the Study of Xenobiotics (ISSX), molecule design
Division: PBPK
  • Read More
Simulations Plus Releases Major Upgrade To GastroPlus(™) Software
  • October 4, 2007
  • Press Release

Simulations Plus Releases Major Upgrade To GastroPlus(™) Software

Keywords: gastrointestinal absorption, molecular structure, pharmaceutical, pharmacokinetics, virtual trials
Software: GastroPlus®
Division: PBPK

Version 5.3 Further Enhances Industry's Gold Standard Product

  • Read More
Experienced Formulation Scientist Becomes Director of Life Sciences
  • September 24, 2007
  • Press Release

Experienced Formulation Scientist Becomes Director of Life Sciences

Keywords: controlled release, dissolution, gastrointestinal absorption, life sciences, Pfizer, Therapeutic Systems Research Laboratories (TSRL)
Division: PBPK

Dr. John Crison Joins Simulations Plus

  • Read More
Simulations Plus and Enslein Research Sign Agreement
  • September 20, 2007
  • Press Release

Simulations Plus and Enslein Research Sign Agreement

Keywords: CYP Enzymes, cytochrome P450 (CYP), Enslein Research of Rochester, metabolism
Division: PBPK

Prediction of Metabolism from Important Group of Enzymes to be Added to ADMET Predictor™

  • Read More
Simulations Plus Announces Stock Dividend
  • September 13, 2007
  • Press Release

Simulations Plus Announces Stock Dividend

Keywords: investor relations, stock dividend
Division: PBPK
  • Read More
Simulations Plus Reports Fourth Quarter and Fiscal Year 2007 Preliminary Revenues
  • September 6, 2007
  • Press Release

Simulations Plus Reports Fourth Quarter and Fiscal Year 2007 Preliminary Revenues

Keywords: investor relations, preliminary revenues
Division: PBPK

Another New Record Set for Quarterly and Annual Revenues

  • Read More
U.S. National Institutes of Health Licenses Simulations Plus’ ClassPharmer™ Software
  • August 30, 2007
  • Press Release

U.S. National Institutes of Health Licenses Simulations Plus’ ClassPharmer™ Software

Keywords: chemistry, ClassPharmer, pharmaceutical, U.S. FDA, U.S. National Institutes of Health
Division: PBPK

Another Government Agency Licenses Key Software Product

  • Read More
U.S. FDA Expands Simulations Plus Software Licenses
  • August 29, 2007
  • Press Release

U.S. FDA Expands Simulations Plus Software Licenses

Keywords: computer-based predictive models, in vitro dissolution, in vitro dissolution experiment simulation software, U.S. FDA
Division: PBPK

GastroPlus and DDDPlus Licenses Added

  • Read More
Simulations Plus Releases Unique Dna Mutation Predictor
  • July 26, 2007
  • Press Release

Simulations Plus Releases Unique Dna Mutation Predictor

Keywords: Bioreason, DNA mutations, molecular property prediction program, mutagenicity, salmonella
Software: ADMET Predictor®
Division: PBPK

New Software Screening Tool Helps Pharmaceutical Chemists Predict Drug-Caused DNA Mutations

  • Read More
Simulations Plus Releases Admet Predictor™ Version 2.3
  • July 24, 2007
  • Press Release

Simulations Plus Releases Admet Predictor™ Version 2.3

Keywords: absorption distribution metabolism and excretion (ADME), ADMET cheminformatics, molecular property prediction software, Toxicity
Software: ADMET Predictor®
Division: PBPK

Predictive Accuracy and User Convenience of Best-in-Class Software Now Further Improved

  • Read More
SImulations Plus to Present at Atlantic City Global Equities Investor Conference July 17
  • July 13, 2007
  • Press Release

SImulations Plus to Present at Atlantic City Global Equities Investor Conference July 17

Keywords: investor conference, Summer Global Equities Conference
Division: PBPK
  • Read More
Simulations Plus Reports Third Quarter FY2007 Financial Results
  • July 3, 2007
  • Press Release

Simulations Plus Reports Third Quarter FY2007 Financial Results

Keywords: financial results, gross profit, net income
Division: PBPK

Third Quarter Surpasses Previous Record in Second Quarter

  • Read More
Simulations Plus Announces Third Quarter Fiscal Year 2007 Earnings Conference Call
  • June 29, 2007
  • Press Release

Simulations Plus Announces Third Quarter Fiscal Year 2007 Earnings Conference Call

Keywords: earnings, investor relations
Division: PBPK

Conference Call to be on Thursday, July 5, at 4:15 PM EDT

  • Read More
Simulations Plus Wins Small Business Innovation Research (SBIR) Grant
  • June 18, 2007
  • Press Release

Simulations Plus Wins Small Business Innovation Research (SBIR) Grant

Keywords: ADMET cheminformatics, molecular descriptors, molecular property prediction software, quantum atomic descriptors, Small Business Innovation Research (SBIR)
Division: PBPK

Grant Funds to Speed Commercialization of Improvements to Company's Industry-Leading Molecular Property Prediction Software

  • Read More
Simulations Plus Set to Join Russell Microcap Index
  • June 14, 2007
  • Press Release

Simulations Plus Set to Join Russell Microcap Index

Keywords: investor relations, Russell Microcap Index
Division: PBPK
  • Read More
  • «
  • 1
  • 2
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • »
Ready to get started?

Sign-up for a free evaluation or schedule a meeting with one of our experts!

Questions? Email info@simulations-plus.com

Discuss my project needs with an expert
Schedule a software demo
Join our newsletter
Software
  • GastroPlus®
  • MonolixSuite™
  • ADMET Predictor®
  • DILIsym®
  • DDDPlus™
  • NAFLDsym®
  • MembranePlus™
  • OBESITYsym™
  • PKanalix®
  • Simulx®
  • IPFsym®
  • ILDsym®
  • MITOsym®
  • MedChem Designer™
  • QSP Software
  • Pro-ficiency Performance Management
  • Panorama KOL Insights Engine
Services
  • Early Drug Discovery
  • Physiologically Based Pharmacokinetics (PBPK)
  • Quantitative Systems Pharmacology (QSP)
  • Clinical Pharmacology & Pharmacometrics (CPP)
  • Regulatory Strategies
  • Pro-ficiency | Clinical Simulations & Medical Communications (CSMC)
  • Concierge
  • Training and Workshops
Resource Center
  • Blog
  • Journal Articles
  • Flyers
  • Posters
  • Presentations
  • Press Releases
  • Videos
  • White Papers
  • Webinars
Investors
  • Board of Directors
  • Environmental, Social and Governance (ESG)
  • Latest Presentations
  • Press Releases
  • SEC Filings
  • Shareholder Information
  • Corporate Development Initiative
About
  • Simulations Plus
  • Contact
  • Careers
  • Leadership
  • Partners and Collaborators
  • Privacy Notice
  • Cookie Notice
  • Vision, Mission & Values
  • FCOI Policy
Support
  • Customer Portal
  • Datasheets
  • Software Installation
  • Contact Support
Simulations Plus
  • GastroPlus
  • Copyright © 2024 Simulations Plus. All Rights Reserved.
    • Privacy Notice
    • Sitemap
    • Terms of Use
    • Cookie Settings
This website uses cookies
We use cookies to enhance your browsing experience and analyze our traffic. To learn more about our use of cookies and other tracking technologies, please see our Cookie Notice and our Privacy Notice. By clicking “Accept All,” you consent to such use by us of cookies and other tracking technologies. To learn more about your privacy rights and our personal data practices, please see our Privacy Notice.
Accept All Reject AllCookie Settings
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. For more information on use of cookies or similar tracking technologies on our website: View our Cookie Notice. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept